Ritholtz Wealth Management Moderna, Inc. Transaction History

Ritholtz Wealth Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 13, 2023	BUY	$96.41 - $126.61 $43,577 - $57,227	452 Added 27.07%	2,122 $219,000
Q2 2023 Jul 14, 2023	BUY	$118.5 - $160.53 $17,182 - $23,276	145 Added 9.51%	1,670 $202,000
Q1 2023 Apr 19, 2023	SELL	$135.66 - $197.02 $96,725 - $140,475	-713 Reduced 31.86%	1,525 $234,000
Q4 2022 Jan 18, 2023	SELL	$118.38 - $210.04 $126,548 - $224,532	-1,069 Reduced 32.33%	2,238 $0
Q3 2022 Oct 18, 2022	BUY	$118.07 - $194.18 $390,457 - $642,153	3,307 New	3,307 $391,000
Q2 2022 Jul 15, 2022	SELL	$117.13 - $176.59 $158,125 - $238,396	-1,350 Closed	0 $0
Q1 2022 Apr 14, 2022	BUY	$126.46 - $235.05 $1,896 - $3,525	15 Added 1.12%	1,350 $233,000
Q4 2021 Jan 18, 2022	SELL	$225.82 - $368.51 $13,775 - $22,479	-61 Reduced 4.37%	1,335 $339,000
Q3 2021 Oct 14, 2021	BUY	$221.9 - $484.47 $309,772 - $676,320	1,396 New	1,396 $537,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Ritholtz Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Ritholtz Wealth Management with notifications on news.